ARID1A and cancer: It was found that ARID1A-deficient OCCC cells are often accompanied by low expression of SLC7A11, resulting in low basal GSH levels and weakening the cancer cells' resistance to oxidative stress, leading to apoptosis (Fig. 2B) [19, 50].